Expression of Topo IIα and P-glycoprotein in Gallbladder Carcinoma and Their Clinical Significance

黄迅,陈祥柏,许峰,赵勇,祝学光,沈丹华,虞有智
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2001.03.007
2001-01-01
Abstract:Objective To investigate the expression of topoisomerase Ⅱα(Topo Ⅱα) and P-glycoprotein (P-gp) in gallbladder carcinoma.Methods The immunohisto-chemical staining for Topo Ⅱα and P-gp was performed in 36 patients with gallbladder neoplasm and 20 patients with chronic cholecystitis. The correlations between the expression of Topo Ⅱα and P-gp and clinical stage, pathological grade of gallbladder carcinoma were analyzed. Results 91 7% gallbladder carcinoma expressed Topo Ⅱα. The positive rate of Topo Ⅱα was higher in poorly differentiated carcinoma than in well differentiated one (P0 05). 58 3% gallbladder carcinoma expressed P-gp and the expression was higher than in the control. Conclusions Topo Ⅱα was expressed highly in the gallbladder neoplasm and could be the target of anti-tumor drugs. Selection of the Topo Ⅱα inhibitors should be the key to improve the efficiency of chemotherapy.
What problem does this paper attempt to address?